Lineage Cell Therapeutics LCTX

$ 0.83 -2.45%

Quarterly report 2024-Q2
added 08-08-2024

Lineage Cell Therapeutics Cash and Cash Equivalents 2011-2024 | LCTX

Annual Cash and Cash Equivalents Lineage Cell Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
35.4 M	11.4 M	55.7 M	32.6 M	9.5 M	23.6 M	36.8 M	22.1 M	42.2 M	29.5 M	5.5 M	4.35 M	22.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
55.7 M	4.35 M	25.5 M

Quarterly Cash and Cash Equivalents Lineage Cell Therapeutics

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
29.6 M	43.6 M	35.4 M	31.5 M	33.9 M	15.5 M	11.4 M	24.8 M	70.9 M	78.1 M	55.7 M	60.8 M	62 M	56.2 M	32.6 M	32.6 M	32.6 M	32.6 M	9.5 M	9.5 M	9.5 M	9.5 M	23.6 M	23.6 M	23.6 M	23.6 M	36.8 M	36.8 M	36.8 M	36.8 M	22.1 M	22.1 M	22.1 M	22.1 M	42.2 M	42.2 M	42.2 M	42.2 M	29.5 M	29.5 M	29.5 M	29.5 M	5.5 M	5.5 M	5.5 M	5.5 M	4.35 M	4.35 M	4.35 M	4.35 M	22.2 M	22.2 M	22.2 M	22.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
78.1 M	4.35 M	28.2 M